These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1744640

  • 1. The apomorphine test in parkinsonian syndromes.
    D'Costa DF, Abbott RJ, Pye IF, Millac PA.
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):870-2. PubMed ID: 1744640
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Apomorphine test in de novo Parkinson's disease.
    Bonuccelli U, Piccini P, Del Dotto P, Pavese N, D'Antonio P, Muratorio A.
    Funct Neurol; 1992 Oct; 7(4):295-8. PubMed ID: 1427361
    [Abstract] [Full Text] [Related]

  • 4. [The apomorphine test for diagnosis of parkinsonian syndrome].
    Piccini P, Del Dotto P, Napolitano A, Pardini C, Bonuccelli U.
    Riv Neurol; 1990 Oct; 60(6):221-3. PubMed ID: 2100046
    [Abstract] [Full Text] [Related]

  • 5. Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
    Imai H, Nakamura T, Kondo T, Narabayashi H.
    Adv Neurol; 1993 Oct; 60():622-5. PubMed ID: 8420201
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes.
    Hughes AJ, Lees AJ, Stern GM.
    Lancet; 1990 Jul 07; 336(8706):32-4. PubMed ID: 1973218
    [Abstract] [Full Text] [Related]

  • 9. [A case at Salpêtrière hospital November 1990. Parkinson syndrome with poor response to dopa therapy in a 64 year-old man].
    Dubas F, Vidailhet M, Henin D.
    Rev Neurol (Paris); 1992 Jul 07; 148(8-9):580-5. PubMed ID: 1494735
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The levodopa test in Parkinson's disease.
    D'Costa DF, Sheehan LJ, Phillips PA, Moore-Smith B.
    Age Ageing; 1995 May 07; 24(3):210-2. PubMed ID: 7645440
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [MRI of degenerative extrapyramidal syndromes. Parkinson disease, progressive supranuclear palsy and multiple system atrophy].
    Elkeslassy A, Miaux Y, Martin-Duverneuil N, Brunet E, Savin D, Chiras J.
    J Neuroradiol; 1996 Dec 07; 23(3):157-63. PubMed ID: 9091608
    [Abstract] [Full Text] [Related]

  • 15. Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report.
    de Bruin VM, Lees AJ, Daniel SE.
    Mov Disord; 1992 Oct 07; 7(4):355-8. PubMed ID: 1484531
    [Abstract] [Full Text] [Related]

  • 16. Clinical features, diagnosis, and imaging of parkinsonian syndromes.
    Poewe W.
    Curr Opin Neurol Neurosurg; 1993 Jun 07; 6(3):333-8. PubMed ID: 8507902
    [Abstract] [Full Text] [Related]

  • 17. Dyskinesia in multiple system atrophy and progressive supranuclear palsy.
    Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A.
    J Neural Transm (Vienna); 2019 Jul 07; 126(7):925-932. PubMed ID: 31087195
    [Abstract] [Full Text] [Related]

  • 18. [Parkinson "plus"].
    Fabre N, Brefel-Courbon C, Rascol O.
    Rev Prat; 1997 May 15; 47(10):1077-82. PubMed ID: 9208670
    [Abstract] [Full Text] [Related]

  • 19. Apomorphine in the diagnosis and treatment of parkinsonian tremor.
    Hughes AJ, Lees AJ, Stern GM.
    Clin Neuropharmacol; 1990 Aug 15; 13(4):312-7. PubMed ID: 2208183
    [Abstract] [Full Text] [Related]

  • 20. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
    Deleu D, Hanssens Y, Northway MG.
    Drugs Aging; 2004 Aug 15; 21(11):687-709. PubMed ID: 15323576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.